Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease

Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease

Introduction: The renal hazard of polypharmacy has never been evaluated in predialysis chronic kidney disease (CKD) patients. Objective: We aimed to analyze the renal hazard of polypharmacy in predialysis CKD patients with stage 1–5. Method: The data of 2,238 patients from a large-scale multicenter...

Full description

Bibliographic Details
Main Authors: Hyang Ki Min, Su Ah Sung, Wookyung Chung, Yeong Hoon Kim, Dong-Wan Chae, Curie Ahn, Kook-Hwan Oh, Sue K. Park, Sung Woo Lee
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Kidney & Blood Pressure Research
Subjects:
chronic kidney disease
polypharmacy
progression
renal hazard
serial medication count
Online Access:https://www.karger.com/Article/FullText/516029

Internet

https://www.karger.com/Article/FullText/516029

Similar Items